NIH-funded research R01 grant

Impact of annual wellness visits on early dementia diagnosis and healthcare quality for Medicare beneficiaries

Official title: Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias

Funded at University of Texas Med Br Galveston · NIH-11092854 · Data updated 2026-11-12

This study is looking at how Annual Wellness Visits can help catch Alzheimer's and related conditions earlier for people on Medicare, especially focusing on improving care for women and minority groups.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Med Br Galveston
NIH-funded
Lab location1 site (Galveston, United States)
Project startAugust 1, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$662,905
NIH project number5R01AG083102-03
Project IDNIH-11092854 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are Medicare beneficiaries, particularly women and individuals from black and Hispanic communities, who are at risk for Alzheimer's Disease and Related Dementias.

Less likely to help

Patients who do not have access to Medicare or those with advanced stages of dementia may not benefit from this research.

What this research studies

This research investigates how Annual Wellness Visits (AWVs) can improve the early diagnosis of Alzheimer's Disease and Related Dementias (ADRD) among Medicare beneficiaries. It aims to assess whether these visits, which include cognitive assessments and personalized prevention plans, can reduce health disparities, particularly among women and minority groups. The study will utilize a mixed-methods approach, analyzing national Medicare data and other health surveys to evaluate the effectiveness of AWVs in enhancing dementia care and reducing inappropriate medication use. By focusing on community-dwelling patients, the research seeks to provide insights into improving healthcare quality for those affected by ADRD.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnoses of dementia, improved healthcare quality, and reduced health disparities for Medicare beneficiaries.

How similar studies have gone: Previous research has shown that early recognition of cognitive impairment can lead to better health outcomes, suggesting that this approach has potential for success.

Where this research is happening

  • University of Texas Med Br Galveston
    Galveston, United States
    Active

Researchers

  • Principal investigator: Tzeng, Huey-Ming — University of Texas Med Br Galveston
  • Study coordinator: Tzeng, Huey-Ming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.